Stark Richard J, Stark Catherine D
Alfred Hospital, Monash University, Melbourne, VIC, Australia.
Med J Aust. 2008 Sep 1;189(5):283-8. doi: 10.5694/j.1326-5377.2008.tb02028.x.
There is a wide array of options for migraine prophylaxis; many of the available drugs are clearly proven to be effective and yet are underused in Australia. "New" drugs which are gaining favour for migraine prophylaxis include topiramate, candesartan, gabapentin and botulinum toxin. The evidence for efficacy is excellent for topiramate and reasonably good but limited for candesartan and gabapentin. The use of botulinum toxin is controversial and has gained substantial popularity through anecdotal experience rather than convincing published evidence. Transformed or chronic migraine with medication overuse is a particularly difficult problem. New strategies to aid in medication withdrawal are reviewed. The approach to menstrual migraine and migraine with prominent aura may differ from that for typical migraine. Novel approaches are being explored for these problems.
偏头痛预防有多种选择;许多现有药物已被明确证明有效,但在澳大利亚却未得到充分使用。越来越受青睐的偏头痛预防“新药”包括托吡酯、坎地沙坦、加巴喷丁和肉毒杆菌毒素。托吡酯的疗效证据确凿,坎地沙坦和加巴喷丁的疗效证据虽合理但有限。肉毒杆菌毒素的使用存在争议,其广泛流行是基于轶事经验而非令人信服的已发表证据。药物过度使用导致的转化型或慢性偏头痛是一个特别棘手的问题。本文综述了有助于停药的新策略。月经性偏头痛和伴有明显先兆的偏头痛的治疗方法可能与典型偏头痛不同。针对这些问题正在探索新的方法。